Ceva Live is an educational seminar series for our customers. Ceva virtual events provide the latest information and education covering the most innovative advancements throughout poultry. Our platform hosts industry leading CEVA scientists presenting on a range of poultry topics, including how Inclusion Body Hepatitis is now recognized as a primary viral disease with sudden increases in mortality. Clinical signs occur within a few hours and often sudden death. No live vaccine is currently available. However, control with Ceva autogenous inactivated IBH vaccines in breeders can be used to help control and prevent IBH with positive outcomes.
Viral arthritis/tenosynovitis has increased incidence of enteric disease since 2020. Certain reovirus serotypes continue to persist but reovirus antigenicity is evolving. Genetic reassortment and mutations likely drive antigenic evolution, which is important to limit reovirus replication and dissemination. Ceva’s new commercial reo product antiserum shows broad cross protection for reovirus in broilers.
Salmonella causes $3.7billion annually in economic losses. In the last few years, one certain serotype of Salmonella has increased over +69%. Ceva autogenous vaccinations reduce Salmonella prevalence, continuing our commitment to autogenous vaccines.
Ceva is proud to announce our most recent expansion in Wisconsin. Recent purchases of Wisconsin and Galant (Canada) facilities provide Ceva seven world class campuses across the globe. Staying dedicated to helping poultry producers respond to new and emerging disease challenges is enhanced through an expanded global presence.
Ceva Live virtual events bring to our customers the most recent research improving bird health and reducing antibiotic usage through disease prevention. We welcome you to partake in these events as we continue to expand our services and offerings through all reachable platforms for our customers.
